Literature DB >> 19360740

Head and neck squamous cell carcinoma in FAMMM syndrome.

Vladimir Vinarsky1, Robert L Fine, Adel Assaad, Ying Qian, John A Chabot, Gloria H Su, Harold Frucht.   

Abstract

BACKGROUND: Germline mutations at the INK4a/p16 locus are implicated in several human cancer syndromes, including familial atypical multiple mole melanoma (FAMMM) syndrome, FAMMM-pancreatic cancer (FAMMM-PC) syndrome, and in familial head and neck cancer syndrome.
METHODS: We present an individual with a family history of melanoma and pancreatic cancer who had multiple dysplastic nevi, squamous cell carcinoma of the tongue at age 22, multiple melanomas, a second squamous cell cancer of the tongue at age 40, and ultimately a pancreatic cancer.
RESULTS: We demonstrate a germline mutation in INK4a and loss of heterozygosity at this locus in his HNSCC tissue.
CONCLUSIONS: This report suggests that INK4a germline mutations associated with FAMMM/FAMMM-PC can also be associated with HNSCC. We conclude that HNSCC in young individuals should prompt clinicians to obtain a family history and consider that the patient may have a germline p16 defect that could predispose them to other cancers, including melanoma and pancreatic cancer. (c) 2009 Wiley Periodicals, Inc. Head Neck, 2009.

Entities:  

Mesh:

Year:  2009        PMID: 19360740     DOI: 10.1002/hed.21050

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.

Authors:  Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2012-04-24       Impact factor: 13.506

2.  Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.

Authors:  Sunil Amin; Russell B McBride; Jennie K Kline; Elana B Mitchel; Aimee L Lucas; Alfred I Neugut; Harold Frucht
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

3.  High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.

Authors:  Aimee L Lucas; Reena Shakya; Marla D Lipsyc; Elana B Mitchel; Sheila Kumar; Caroline Hwang; Liyong Deng; Catherine Devoe; John A Chabot; Matthias Szabolcs; Thomas Ludwig; Wendy K Chung; Harold Frucht
Journal:  Clin Cancer Res       Date:  2013-05-08       Impact factor: 12.531

4.  Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.

Authors:  Morgan A Gingerich; Joshua D Smith; Nicole L Michmerhuizen; Megan Ludwig; Samantha Devenport; Chloe Matovina; Chad Brenner; Steven B Chinn
Journal:  Head Neck       Date:  2018-02-10       Impact factor: 3.147

5.  RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).

Authors:  Kathrin Scheckenbach; Stephan E Baldus; Vera Balz; Marcel Freund; Petra Pakropa; Christoph Sproll; Karl-Ludwig Schäfer; Martin Wagenmann; Jörg Schipper; Helmut Hanenberg
Journal:  Oral Oncol       Date:  2013-12-06       Impact factor: 5.337

6.  Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program.

Authors:  Aimee L Lucas; Adam Tarlecki; Kellie Van Beck; Casey Lipton; Arindam RoyChoudhury; Elana Levinson; Sheila Kumar; Wendy K Chung; Harold Frucht; Jeanine M Genkinger
Journal:  J Genet Couns       Date:  2016-12-30       Impact factor: 2.537

7.  CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.

Authors:  Robert R McWilliams; Eric D Wieben; Kari G Chaffee; Samuel O Antwi; Leon Raskin; Olufunmilayo I Olopade; Donghui Li; W Edward Highsmith; Gerardo Colon-Otero; Lauren G Khanna; Jennifer B Permuth; Janet E Olson; Harold Frucht; Jeanine Genkinger; Wei Zheng; William J Blot; Lang Wu; Luciana L Almada; Martin E Fernandez-Zapico; Hugues Sicotte; Katrina S Pedersen; Gloria M Petersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

8.  BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.

Authors:  Aimee L Lucas; Laura E Frado; Caroline Hwang; Sheila Kumar; Lauren G Khanna; Elana J Levinson; John A Chabot; Wendy K Chung; Harold Frucht
Journal:  Cancer       Date:  2014-04-15       Impact factor: 6.860

Review 9.  Precision Therapy of Head and Neck Squamous Cell Carcinoma.

Authors:  P J Polverini; N J D'Silva; Y L Lei
Journal:  J Dent Res       Date:  2018-04-12       Impact factor: 6.116

10.  Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.

Authors:  Thomas P Potjer; Heidi E Kranenburg; Wilma Bergman; Wouter H de Vos tot Nederveen Cappel; Hester S van Monsjou; Daniela Q C M Barge-Schaapveld; Hans F A Vasen
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.